POSLUDI

Welcome to the Brand page for “POSLUDI”, which is offered here for (based on 44(e)) antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of hiv/aids; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for treatment of myelofibrosis, myeloma, leukemia, and lymphoma;.

Its status is currently believed to be active. Its class is unavailable. “POSLUDI” is believed to be currently owned by “GILEAD SCIENCES IRELAND UC”.

Owner:
GILEAD SCIENCES IRELAND UC
Owner Details
Description:
(Based on 44(e)) Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV/AIDS; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for treatment of myelofibrosis, myeloma, leukemia, and lymphoma; awais description is rendring
Categories: BASED ON E ANTIVIRAL PHARMACEUTICAL